Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma.

@article{Greto2018SafetyOC,
  title={Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma.},
  author={Daniela Greto and Mauro Loi and Calogero Saieva and Cristina Muntoni and Carlotta Becherini and Cinzia Ciabatti and Marco Di Perna and Domenico Andrea Campanacci and Francesca Terziani and Giovanni Beltrami and Guido Scoccianti and Pierluigi Bonomo and Icro Meattini and Isacco Desideri and Gabriele Simontacchi and Monica Mangoni and Lorenzo Livi},
  journal={Tumori},
  year={2018},
  volume={104 5},
  pages={
          322-329
        }
}
INTRODUCTION: This retrospective study analyzes the safety and feasibility of concurrent chemoradiotherapy (CRT) in adjuvant treatment of soft tissue sarcoma (STS). METHODS: A total of 158 patients with STS were retrospectively analyzed. Anthracycline-based computed tomography was performed in high-risk patients. Acute radiotherapy toxicity and chemotherapy-related toxicity were assessed according to the Common Terminology Criteria for Adverse Events 4.0; late radiotherapy toxicity was… CONTINUE READING
BETA